Catherine Longeval speaks at ERA’s “Annual Conference on EU LAW in the Pharmaceutical Sector 2019” in Brussels
On 22 February 2019, Van Bael & Bellis partner Catherine Longeval was a speaker at ERA’s “Annual Conference on EU LAW in the Pharmaceutical Sector 2019” in Brussels. The topic of Catherine’s presentation was ”Off-label use: impact of the CJEU decision in Novartis Farma v. AIFA, Roche Italia and others (Avastin / Lucentis - C-29/17)”. Her presentation was followed by a lively Q&A session with the conference delegates. You will find the program of the ERA Conference here.
Related insightsSign up for updates